Free Trial

Aberdeen Group plc Purchases 3,883,199 Shares of Novanta Inc. $NOVT

Novanta logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Aberdeen Group purchased 3,883,199 Novanta shares in the third quarter, worth about $552 million, making the company a 0.6% portfolio holding and Aberdeen’s 28th-largest position.
  • Analyst views are mixed: ratings span buy, hold and sell, with a consensus Hold rating and a $175 price target.
  • Novanta beat quarterly estimates, reporting EPS of $1.05 versus $0.97 expected and revenue of $305 million; revenue rose 23.1% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Aberdeen Group plc purchased a new stake in shares of Novanta Inc. (NASDAQ:NOVT - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 3,883,199 shares of the technology company's stock, valued at approximately $552,152,000. Novanta accounts for approximately 0.6% of Aberdeen Group plc's investment portfolio, making the stock its 28th largest position. Aberdeen Group plc owned 10.27% of Novanta as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the company. State Street Corp boosted its stake in Novanta by 7.3% during the second quarter. State Street Corp now owns 1,436,785 shares of the technology company's stock valued at $233,005,000 after buying an additional 97,621 shares during the last quarter. Tidal Investments LLC boosted its holdings in Novanta by 615.8% during the 2nd quarter. Tidal Investments LLC now owns 34,631 shares of the technology company's stock valued at $5,619,000 after acquiring an additional 29,793 shares during the period. Bank of America Corp DE boosted its stake in shares of Novanta by 18.3% during the first quarter. Bank of America Corp DE now owns 456,241 shares of the technology company's stock valued at $53,887,000 after purchasing an additional 70,728 shares during the period. Oppenheimer Asset Management Inc. purchased a new position in Novanta in the 2nd quarter worth about $5,797,000. Finally, Wellington Management Group LLP boosted its position in Novanta by 10.5% in the 2nd quarter. Wellington Management Group LLP now owns 460,896 shares of the technology company's stock valued at $74,776,000 after buying an additional 43,659 shares during the period. Hedge funds and other institutional investors own 98.35% of the company's stock.

Analyst Ratings Changes

NOVT has been the subject of several research analyst reports. Robert W. Baird decreased their price target on shares of Novanta from $194.00 to $175.00 and set an "outperform" rating for the company in a research note on Thursday. Wall Street Zen raised Novanta from a "hold" rating to a "buy" rating in a research note on Saturday, November 7th. Zacks Research downgraded Novanta from a "strong-buy" rating to a "hold" rating in a report on Tuesday, October 6th. Finally, Weiss Ratings lowered Novanta from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Tuesday. One equities research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus price target of $175.00.

Get Our Latest Stock Analysis on NOVT

Novanta Stock Up 1.2%

Shares of NOVT stock opened at $118.88 on Friday. The stock's 50-day simple moving average is $140.29 and its 200-day simple moving average is $142.25. The company has a debt-to-equity ratio of 0.48, a quick ratio of 3.79 and a current ratio of 1.18. The firm has a market capitalization of $4.50 billion, a PE ratio of 32.08, a P/E/G ratio of 2.55 and a beta of 1.71. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $176.38.

Novanta (NASDAQ:NOVT - Get Free Report) last announced its quarterly earnings data on Monday, November 9th. The technology company reported $1.05 EPS for the quarter, beating the consensus estimate of $0.97 by $0.08. The business had revenue of $305.01 million during the quarter, compared to analysts' expectations of $301.02 million. Novanta had a net margin of 4.89% and a return on equity of 10.23%. The business's quarterly revenue was up 23.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.87 EPS. Equities analysts expect that Novanta Inc. will post 3.68 earnings per share for the current year.

Novanta Profile

(Free Report)

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software. The company's technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

See Also

Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT - Free Report).

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines